Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Arrhythmias

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 321 articles:
HTML format



Single Articles


    September 2020
  1. TOMLINSON DR, Mandrola J
    Pulsed Field Ablation for Persistent Atrial Fibrillation (PersAFOne): Hope or Hype?
    J Am Coll Cardiol. 2020;76:1081-1083.
    PubMed    


  2. REDDY VY, Anic A, Koruth J, Petru J, et al
    Pulsed Field Ablation in Patients With Persistent Atrial Fibrillation.
    J Am Coll Cardiol. 2020;76:1068-1080.
    PubMed     Abstract available


  3. KOSMALA W
    Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: How to Fight Allied Enemies.
    J Am Coll Cardiol. 2020;76:1065-1067.
    PubMed    


  4. REDDY YNV, Obokata M, Verbrugge FH, Lin G, et al
    Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.
    J Am Coll Cardiol. 2020;76:1051-1064.
    PubMed     Abstract available


    July 2020
  5. NAZARI MA, Rosenblum JS, Haigney MC, Rosing DR, et al
    Pathophysiology and Acute Management of Tachyarrhythmias in Pheochromocytoma: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:451-464.
    PubMed     Abstract available


  6. POOLE JE, Olshansky B, Mark DB, Anderson J, et al
    Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.
    J Am Coll Cardiol. 2020;76:405-415.
    PubMed     Abstract available


  7. CALKINS H
    Important Differences Exist Between Atrial Fibrillation and Atrial Flutter in Atrial Remodeling.
    J Am Coll Cardiol. 2020;76:389-390.
    PubMed    


  8. GUICHARD JB, Naud P, Xiong F, Qi X, et al
    Comparison of Atrial Remodeling Caused by Sustained Atrial Flutter Versus Atrial Fibrillation.
    J Am Coll Cardiol. 2020;76:374-388.
    PubMed     Abstract available


  9. POKORNEY SD, Black-Maier E, Piccini JP
    Reply: Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease.
    J Am Coll Cardiol. 2020;76:351-352.
    PubMed    


  10. JAAKKOLA S, Nuotio I, Hartikainen JEK, Airaksinen KEJ, et al
    Early Cardioversion for Acute Atrial Fibrillation in Low Stroke Risk Patients Is Safe Without Anticoagulation.
    J Am Coll Cardiol. 2020;76:226-227.
    PubMed    


  11. PERETTO G, Sala S, Della Bella P, Basso C, et al
    Reply: Genetic Basis for Acute Myocarditis Presenting With Ventricular Arrhythmias?
    J Am Coll Cardiol. 2020;76:126-128.
    PubMed    


  12. KALRA R, Nijjar PS
    Genetic Basis for Acute Myocarditis Presenting With Ventricular Arrhythmias?
    J Am Coll Cardiol. 2020;76:126.
    PubMed    


    June 2020
  13. OSMANCIK P, Herman D, Neuzil P, Hala P, et al
    Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:3122-3135.
    PubMed     Abstract available


  14. POOLE JE, Bahnson TD, Monahan KH, Johnson G, et al
    Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial.
    J Am Coll Cardiol. 2020;75:3105-3118.
    PubMed     Abstract available


  15. GOLLOB MH
    COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm.
    J Am Coll Cardiol. 2020;75:3184-3186.
    PubMed    


  16. CHANG D, Saleh M, Gabriels J, Ismail H, et al
    Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin.
    J Am Coll Cardiol. 2020;75:2992-2993.
    PubMed    


  17. BLUEMKE DA, James CA, Te Riele ASJM
    Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: Not a One-Size-Fits-All Strategy.
    J Am Coll Cardiol. 2020;75:2766-2768.
    PubMed    


  18. AQUARO GD, De Luca A, Cappelletto C, Raimondi F, et al
    Prognostic Value of Magnetic Resonance Phenotype in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    J Am Coll Cardiol. 2020;75:2753-2765.
    PubMed     Abstract available


    May 2020
  19. RODEN DM, Harrington RA, Poppas A, Russo AM, et al
    Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment.
    J Am Coll Cardiol. 2020;75:2623-2624.
    PubMed    


  20. BOUTJDIR M, Lazzerini PE
    A Novel Peptide/Antibody-Based Antiarrhythmic Approach to Long QT Syndrome and Beyond.
    J Am Coll Cardiol. 2020;75:2153-2155.
    PubMed    


  21. MAGUY A, Kucera JP, Wepfer JP, Forest V, et al
    KCNQ1 Antibodies for Immunotherapy of Long QT Syndrome Type 2.
    J Am Coll Cardiol. 2020;75:2140-2152.
    PubMed     Abstract available


    April 2020
  22. GALLI M, Andreotti F, D'Amario D, Porto I, et al
    Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation-ACS/PCI Trials.
    J Am Coll Cardiol. 2020;75:1727-1728.
    PubMed    


  23. MADIAS C, Parzynski CS, Burrows A, Minges KE, et al
    Utilization Effects of the Affordable Care Act on Implantable Cardioverter-Defibrillator Therapy.
    J Am Coll Cardiol. 2020;75:1714-1717.
    PubMed    


  24. CHUNG MK, Refaat M, Shen WK, Kutyifa V, et al
    Atrial Fibrillation: JACC Council Perspectives.
    J Am Coll Cardiol. 2020;75:1689-1713.
    PubMed     Abstract available


  25. RUFF CT
    The Promise of Mobile Health in Managing Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1535-1537.
    PubMed    


  26. GUO Y, Lane DA, Wang L, Zhang H, et al
    Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1523-1534.
    PubMed     Abstract available


    March 2020
  27. GUO Y, Liu T, Chen Y, Lip GYH, et al
    Reply: Observations From the Huawei Heart Study Using Photoplethysmography-Based Smart Devices for Atrial Fibrillation Screening.
    J Am Coll Cardiol. 2020;75:1366-1367.
    PubMed    


  28. EERIKAINEN LM, Bonomi AG, Dekker LRC, Aarts RM, et al
    Atrial Fibrillation Episodes Detected Using Photoplethysmography: Do We Know Which Are True?
    J Am Coll Cardiol. 2020;75:1365.
    PubMed    


  29. ANANTHAN K
    The Efficacy and Feasibility of Atrial Fibrillation Screening Using Photoplethysmography-Based Smart Devices.
    J Am Coll Cardiol. 2020;75:1365-1366.
    PubMed    


  30. SEPEHRI SHAMLOO A, Bollmann A, Dagres N, Arya A, et al
    Smart Watch Devices for Atrial Fibrillation Screening: It Has to Start Somewhere.
    J Am Coll Cardiol. 2020;75:1364-1365.
    PubMed    


  31. PONG T, Cyr K, Niesen J, Aparicio-Valenzuela J, et al
    Screening and Prophylactic Amiodarone Reduces Post-Operative Atrial Fibrillation in At-Risk Patients.
    J Am Coll Cardiol. 2020;75:1361-1363.
    PubMed    


  32. POKORNEY SD, Black-Maier E, Hellkamp AS, Friedman DJ, et al
    Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease.
    J Am Coll Cardiol. 2020;75:1299-1308.
    PubMed     Abstract available


  33. DRIGGIN E, Madhavan MV, Bikdeli B, Chuich T, et al
    Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic.
    J Am Coll Cardiol. 2020 Mar 18. pii: S0735-1097(20)34637.
    PubMed     Abstract available


  34. CHENG EP, Yeo I, Kim LK, Lerman BB, et al
    Reply: Early Mortality Following Catheter Ablation of Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1245-1247.
    PubMed    


  35. REN JF, Chen S, Callans DJ, Jiang C, et al
    Role of Intracardiac Echocardiography for Catheter Ablation of Atrial Fibrillation: Reduction of Complications and Mortality.
    J Am Coll Cardiol. 2020;75:1244-1245.
    PubMed    


  36. BOLLMANN A, Konig S, Basedow F, Hindricks G, et al
    Early Mortality After Catheter Ablation of Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:1243-1244.
    PubMed    


  37. COOPER LT JR
    Ventricular Arrhythmias and Sudden Cardiac Death in Lymphocytic Myocarditis.
    J Am Coll Cardiol. 2020;75:1058-1060.
    PubMed    


  38. PERETTO G, Sala S, Rizzo S, Palmisano A, et al
    Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation.
    J Am Coll Cardiol. 2020;75:1046-1057.
    PubMed     Abstract available


    February 2020
  39. SIONTIS KC, Checkole S, Yao X, Gersh BJ, et al
    Do Observational Studies Agree With Randomized Trials?: Evaluation of Oral Anticoagulants in Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:562-563.
    PubMed    


  40. VIJAYARAMAN P, Nayak HM, Ellenbogen KA
    Left Ventricular Septal Versus Left Bundle Branch Pacing: A New Beginning in Cardiac Resynchronization Therapy?
    J Am Coll Cardiol. 2020;75:360-362.
    PubMed    


  41. SALDEN FCWM, Luermans JGLM, Westra SW, Weijs B, et al
    Short-Term Hemodynamic and Electrophysiological Effects of Cardiac Resynchronization by Left Ventricular Septal Pacing.
    J Am Coll Cardiol. 2020;75:347-359.
    PubMed     Abstract available


    January 2020
  42. WALD R, Dorian P, Harel Z
    Benefits and Risks of Anticoagulation in Dialysis Patients With Nonvalvular Atrial Fibrillation: Navigating Through Darkness.
    J Am Coll Cardiol. 2020;75:286-288.
    PubMed    


  43. KUNO T, Takagi H, Ando T, Sugiyama T, et al
    Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis.
    J Am Coll Cardiol. 2020;75:273-285.
    PubMed     Abstract available


  44. STEG PG, Ducrocq G, Bhatt DL, Hohnloser SH, et al
    Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post PCI in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2020;75:238-240.
    PubMed    


  45. BISBAL F, Baranchuk A, Braunwald E, Bayes de Luna A, et al
    Atrial Failure as a Clinical Entity: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:222-232.
    PubMed     Abstract available


  46. COHEN A
    Is Persistent Isolation of the LAA Necessary to Achieve Higher Success Rates in Atrial Fibrillation?
    J Am Coll Cardiol. 2020;75:128-129.
    PubMed    


  47. REDDY VY
    Reply: Common Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation: A Neurologist's and Neuroradiologist's Perspective.
    J Am Coll Cardiol. 2020;75:127-128.
    PubMed    


  48. PAPANAGIOTOU P, Tsivgoulis G
    Common Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation: A Neurologist's and Neuroradiologist's Perspective.
    J Am Coll Cardiol. 2020;75:126-127.
    PubMed    


  49. PAGANO G, Cannavo A, Rengo G
    Is the Hitman in Cardiac Death Hidden in the Sympathetic Nervous System Remodeling?
    J Am Coll Cardiol. 2020;75:14-16.
    PubMed    


  50. DI BIASE L, Mohanty S, Romero J, Della Rocca DG, et al
    Reply: LAA Electrical Isolation: A Tool to Achieve Superior Ablation Success Under Protection of Optimal Anticoagulation.
    J Am Coll Cardiol. 2020;75:130-131.
    PubMed    


  51. ADELINO R, Bazan V, Villuendas R, Bisbal F, et al
    Left Atrial Appendage Isolation and Preserved Function: Is it Really Isolated?
    J Am Coll Cardiol. 2020;75:129-130.
    PubMed    


  52. TAN AY, Elharrif K, Cardona-Guarache R, Mankad P, et al
    Persistent Proarrhythmic Neural Remodeling Despite Recovery From Premature Ventricular Contraction-Induced Cardiomyopathy.
    J Am Coll Cardiol. 2020;75:1-13.
    PubMed     Abstract available


    December 2019
  53. RUSSAK AJ, Johnson KW, Halperin JL, Percha B, et al
    Racial and Sex Differences in Stroke Risk in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:3069-3070.
    PubMed    


  54. ALKHOULI M, Friedman PA
    Ischemic Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:3050-3065.
    PubMed     Abstract available


  55. GUE YX, Inoue N, Spinthakis N, Takei A, et al
    Thrombotic Profile and Oral Anticoagulation in Asian and Non-Asian Patients With Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:2822-2824.
    PubMed    


  56. VOLGMAN AS, Bairey Merz CN, Benjamin EJ, Curtis AB, et al
    Sex and Race/Ethnicity Differences in Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:2812-2815.
    PubMed    


  57. GLOTZER TV
    The Naissance of Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:2782-2785.
    PubMed    


  58. DIEDERICHSEN SZ, Haugan KJ, Brandes A, Lanng MB, et al
    Natural History of Subclinical Atrial Fibrillation Detected by Implanted Loop Recorders.
    J Am Coll Cardiol. 2019;74:2771-2781.
    PubMed     Abstract available


    November 2019
  59. OBOKATA M, Reddy YNV, Shah SJ, Kaye DM, et al
    Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2019;74:2539-2550.
    PubMed     Abstract available


  60. QAMAR A, Antman EM, Giugliano RP
    Reply: Anticoagulants in Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;74:2436-2437.
    PubMed    


  61. PIGNATELLI P, Pastori D, Violi F
    Anticoagulants in Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;74:2436.
    PubMed    


  62. LIP GYH, Bhatt DL, Hohnloser SH, Kimura T, et al
    Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation Post-PCI: Time in Therapeutic Range.
    J Am Coll Cardiol. 2019;74:2431-2433.
    PubMed    


  63. CHOI EK, Lee SR, Oh S, Lip GYH, et al
    Reply: Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;74:2330-2331.
    PubMed    


  64. GUO W, Tian X, Qiu L, Li L, et al
    Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;74:2329-2330.
    PubMed    


  65. SHARMA SP, Turagam MK, Gopinathannair R, Reddy V, et al
    Direct Current Cardioversion of Atrial Fibrillation in Patients With Left Atrial Appendage Occlusion Devices.
    J Am Coll Cardiol. 2019;74:2267-2274.
    PubMed     Abstract available


  66. CALKINS H
    When it Comes to the Mortality Rates of Catheter Ablation of Atrial Fibrillation, Experience Matters.
    J Am Coll Cardiol. 2019;74:2265-2266.
    PubMed    


  67. CHENG EP, Liu CF, Yeo I, Markowitz SM, et al
    Risk of Mortality Following Catheter Ablation of Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:2254-2264.
    PubMed     Abstract available


    October 2019
  68. KUMAR S, Lim E, Covic A, Verhamme P, et al
    Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:2204-2215.
    PubMed     Abstract available


  69. GAGE BF
    Warfarin-Induced Fractures in Atrial Fibrillation?
    J Am Coll Cardiol. 2019;74:2159-2161.
    PubMed    


  70. BINDING C, Bjerring Olesen J, Abrahamsen B, Staerk L, et al
    Osteoporotic Fractures in Patients With Atrial Fibrillation Treated With Conventional Versus Direct Anticoagulants.
    J Am Coll Cardiol. 2019;74:2150-2158.
    PubMed     Abstract available


  71. CHAMBERLAIN AM
    Secondhand Smoke and Atrial Fibrillation: Importance of Managing Modifiable Risk Factors.
    J Am Coll Cardiol. 2019;74:1665-1666.
    PubMed    


  72. GROH CA, Vittinghoff E, Benjamin EJ, Dupuis J, et al
    Childhood Tobacco Smoke Exposure and Risk of Atrial Fibrillation in Adulthood.
    J Am Coll Cardiol. 2019;74:1658-1664.
    PubMed     Abstract available


    September 2019
  73. SARDANA M, Hsue PY, Tseng ZH, Vittinghoff E, et al
    Human Immunodeficiency Virus Infection and Incident Atrial Fibrillation.
    J Am Coll Cardiol. 2019;74:1512-1514.
    PubMed    


  74. KOTTKAMP H
    On the Atrial Fibrillation Substrate: From the "Unknown Species" to Deeper Insights Into Pathophysiology.
    J Am Coll Cardiol. 2019;74:1348-1351.
    PubMed    


  75. HIRAM R, Naud P, Xiong F, Al-U'datt D, et al
    Right Atrial Mechanisms of Atrial Fibrillation in a Rat Model of Right Heart Disease.
    J Am Coll Cardiol. 2019;74:1332-1347.
    PubMed     Abstract available


    August 2019
  76. WANG A, Green JB, Halperin JL, Piccini JP Sr, et al
    Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:1107-1115.
    PubMed     Abstract available


  77. DI BIASE L, Mohanty S, Trivedi C, Romero J, et al
    Stroke Risk in Patients With Atrial Fibrillation Undergoing Electrical Isolation of the Left Atrial Appendage.
    J Am Coll Cardiol. 2019;74:1019-1028.
    PubMed     Abstract available


  78. RODES-CABAU J, Ellenbogen KA, Krahn AD, Latib A, et al
    Management of Conduction Disturbances Associated With Transcatheter Aortic Valve Replacement: JACC Scientific Expert Panel.
    J Am Coll Cardiol. 2019;74:1086-1106.
    PubMed     Abstract available


  79. DESHAIES C, Hamilton RM, Shohoudi A, Trottier H, et al
    Thromboembolic Risk After Atriopulmonary, Lateral Tunnel, and Extracardiac Conduit Fontan Surgery.
    J Am Coll Cardiol. 2019;74:1071-1081.
    PubMed     Abstract available


  80. GUO Y, Wang H, Zhang H, Liu T, et al
    Mobile Health Technology for Atrial Fibrillation Screening Using Photoplethysmography-Based Smart Devices: The HUAWEI Heart study.
    J Am Coll Cardiol. 2019 Aug 22. pii: S0735-1097(19)36365.
    PubMed     Abstract available


  81. MIYOSHI T, Maeno Y, Hamasaki T, Inamura N, et al
    Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.
    J Am Coll Cardiol. 2019;74:874-885.
    PubMed     Abstract available


  82. ZOGHBI WA
    Should Left Atrial Size Influence the Decision to Intervene in Degenerative Mitral Regurgitation?
    J Am Coll Cardiol. 2019;74:871-873.
    PubMed    


  83. ESSAYAGH B, Antoine C, Benfari G, Messika-Zeitoun D, et al
    Prognostic Implications of Left Atrial Enlargement in Degenerative Mitral Regurgitation.
    J Am Coll Cardiol. 2019;74:858-870.
    PubMed     Abstract available


  84. NESTELBERGER T, Boeddinghaus J, Wussler D, Twerenbold R, et al
    Predicting Major Adverse Events in Patients With Acute Myocardial Infarction.
    J Am Coll Cardiol. 2019;74:842-854.
    PubMed     Abstract available


    July 2019
  85. CHOI EK, Lee SR
    DOACs in Patients With Atrial Fibrillation and Liver Disease: Time to Expand the Safety Zone?
    J Am Coll Cardiol. 2019;74:190-192.
    PubMed    


  86. QAMAR A, Antman EM, Ruff CT, Nordio F, et al
    Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease.
    J Am Coll Cardiol. 2019;74:179-189.
    PubMed     Abstract available


  87. CAPODANNO D, Huber K, Mehran R, Lip GYH, et al
    Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;74:83-99.
    PubMed     Abstract available


  88. HUANG B
    Atrial Fibrillation Accompanying Mitral Stenosis: Another Fortress Captured by Direct Oral Anticoagulants?
    J Am Coll Cardiol. 2019;73:3361-3362.
    PubMed    


  89. GIANCATERINO S, Hsu JC
    Valvular Atrial Fibrillation: A Confusing and Obsolete Definition.
    J Am Coll Cardiol. 2019;73:3360-3361.
    PubMed    


  90. LEE SR, Lee HJ, Choi EK, Han KD, et al
    Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease.
    J Am Coll Cardiol. 2019;73:3295-3308.
    PubMed     Abstract available


  91. KIM JY, Kim SH
    Reply: Off-Label Use of Direct Oral Anticoagulants in Patients With Mitral Stenosis.
    J Am Coll Cardiol. 2019;73:3362-3363.
    PubMed    


  92. ZHOU Z
    Efficacy and Safety of Direct Oral Anticoagulants in Patients With Mitral Stenosis.
    J Am Coll Cardiol. 2019;73:3362.
    PubMed    


    June 2019
  93. VERHEUGT FWA, Ten Berg JM, Storey RF, Cuisset T, et al
    Antithrombotic Agents: From Aspirin to DOACs in Coronary Artery Disease and in Atrial Fibrillation (Part I).
    J Am Coll Cardiol. 2019 Jun 27. pii: S0735-1097(19)35400.
    PubMed     Abstract available


  94. GOLD MR, Koerber SM
    Electrocardiogram in Cardiac Resynchronization Therapy: Is Non-Left Bundle Branch Block an Oversimplification?
    J Am Coll Cardiol. 2019;73:3100-3101.
    PubMed    


  95. EL-AM EA, Dispenzieri A, Grogan M, Nkomo VT, et al
    Reply: Cardiac Amyloidosis, Atrial Arrhythmias, Thrombus, and Stroke: A Vexing Problem.
    J Am Coll Cardiol. 2019;73:2911-2913.
    PubMed    


  96. RUSSO D, Limite LR, Arcari L, Autore C, et al
    Predicting the Unpredictable: How to Score the Risk of Stroke in Cardiac Amyloidosis?
    J Am Coll Cardiol. 2019;73:2910-2911.
    PubMed    


  97. CSECS I, Merkely B, Wilson BD
    Cardiac Amyloidosis and Electrical Cardioversion: Is the Thrombus There or Not?
    J Am Coll Cardiol. 2019;73:2909-2910.
    PubMed    


  98. DEFILIPPI C, Seliger S, Latta F, Peters M, et al
    High-Sensitivity Cardiac Troponin Assays Potentially Differentiate Acute From Chronic Myocardial Injury.
    J Am Coll Cardiol. 2019;73:2904-2905.
    PubMed    


    May 2019
  99. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Major Adverse Events With Percutaneous Left Atrial Appendage Closure in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:2638-2640.
    PubMed    


  100. BIRGERSDOTTER-GREEN U, Eskander MA
    Delayed Atrioventricular Block Following Transcatheter Aortic Valve Replacement: Risk Stratification or Crystal Ball?
    J Am Coll Cardiol. 2019;73:2548-2549.
    PubMed    


  101. REAM K, Sandhu A, Valle J, Weber R, et al
    Ambulatory Rhythm Monitoring to Detect Late High-Grade Atrioventricular Block Following Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2019;73:2538-2547.
    PubMed     Abstract available


  102. ARIGA R, Tunnicliffe EM, Manohar SG, Mahmod M, et al
    Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
    J Am Coll Cardiol. 2019;73:2493-2502.
    PubMed     Abstract available


  103. MCKENNA WJ, Moon JC, Sulaiman A
    Understanding the Myocardial Architecture of Hypertrophic Cardiomyopathy for Clinical Care.
    J Am Coll Cardiol. 2019;73:2503-2505.
    PubMed    


  104. CRAWFORD TC
    Pacemaker Mortality After Surgical Ablation for Atrial Fibrillation: What Is Success and Failure?
    J Am Coll Cardiol. 2019;73:2436-2438.
    PubMed    


  105. DEROSE JJ JR, Mancini DM, Chang HL, Argenziano M, et al
    Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation Ablation.
    J Am Coll Cardiol. 2019;73:2427-2435.
    PubMed     Abstract available


  106. DEFERM S, Bertrand PB, Verbrugge FH, Verhaert D, et al
    Atrial Functional Mitral Regurgitation: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:2465-2476.
    PubMed     Abstract available


  107. SHINNAWI R, Shaheen N, Huber I, Shiti A, et al
    Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.
    J Am Coll Cardiol. 2019;73:2310-2324.
    PubMed     Abstract available


  108. HULOT JS
    Modeling Cardiac Arrhythmias With Organoids.
    J Am Coll Cardiol. 2019;73:2325-2327.
    PubMed    


  109. HUIZAR JF, Ellenbogen KA, Tan AY, Kaszala K, et al
    Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2019;73:2328-2344.
    PubMed     Abstract available


  110. REDDY VY, Neuzil P, de Potter T, van der Heyden J, et al
    A Percutaneous Permanent Carotid Filter for Stroke Prevention in Atrial Fibrillation: The CAPTURE Trial.
    J Am Coll Cardiol. 2019 May 8. pii: S0735-1097(19)35006.
    PubMed     Abstract available


    April 2019
  111. DE FERRARI GM, Dusi V, Ruffinazzi M, Gionti V, et al
    Physical Inactivity Is a Risk Factor for Primary Ventricular Fibrillation.
    J Am Coll Cardiol. 2019;73:2117-2118.
    PubMed    


  112. REDDY VY, Neuzil P, Koruth JS, Petru J, et al
    Pulsed Field Ablation for Pulmonary Vein Isolation in Atrial Fibrillation.
    J Am Coll Cardiol. 2019 Apr 29. pii: S0735-1097(19)34933.
    PubMed     Abstract available


  113. FRIEDMAN DJ, Pokorney SD, Khanna R, Goldstein L, et al
    Catheter Ablation of Atrial Fibrillation With and Without On-Site Cardiothoracic Surgery.
    J Am Coll Cardiol. 2019 Apr 29. pii: S0735-1097(19)33808.
    PubMed    


  114. PIERONI M, Notarstefano P, Bolognese L
    Brugada Syndrome in the Young and in the Adult: A Tale of 2 Diseases?
    J Am Coll Cardiol. 2019;73:1766-1768.
    PubMed    


  115. MAZZANTI A, Ovics P, Shauer A, Mameli S, et al
    Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome.
    J Am Coll Cardiol. 2019;73:1868-1869.
    PubMed    


  116. MICHOWITZ Y, Milman A, Andorin A, Sarquella-Brugada G, et al
    Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome.
    J Am Coll Cardiol. 2019;73:1756-1765.
    PubMed     Abstract available


  117. ECKHARDT LL, Kalscheur MM
    Replacing Hardware With "Viralware".
    J Am Coll Cardiol. 2019;73:1688-1690.
    PubMed    


  118. DAWKINS JF, Hu YF, Valle J, Sanchez L, et al
    Antegrade Conduction Rescues Right Ventricular Pacing-Induced Cardiomyopathy in Complete Heart Block.
    J Am Coll Cardiol. 2019;73:1673-1687.
    PubMed     Abstract available


  119. STEVENSON WG, Tedrow UB, Reddy V, AbdelWahab A, et al
    Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricular Arrhythmias.
    J Am Coll Cardiol. 2019;73:1413-1425.
    PubMed     Abstract available


  120. SHAH KS, Held EP
    Utilizing Biomarkers to Refine Risk Prediction in Atrial Fibrillation: A Step Toward Precision Medicine.
    J Am Coll Cardiol. 2019;73:1411-1412.
    PubMed    


  121. RAVASSA S, Ballesteros G, Lopez B, Ramos P, et al
    Combination of Circulating Type I Collagen-Related Biomarkers Is Associated With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:1398-1410.
    PubMed     Abstract available


  122. HSIA HH, Xiong N
    Infusion Needle Ablation Catheter: An Evolution of Needs.
    J Am Coll Cardiol. 2019;73:1426-1429.
    PubMed    


  123. DEZORZI C, Boyle B, Qazi A, Luthra K, et al
    Administrative Billing Codes for Identifying Patients With Cardiac Arrest.
    J Am Coll Cardiol. 2019;73:1598-1600.
    PubMed    


    March 2019
  124. PIERONI M, Notarstefano P, Oliva A, Santangeli P, et al
    Reply: Myocardial Inflammation in Brugada Syndrome.
    J Am Coll Cardiol. 2019;73:1370.
    PubMed    


  125. MILES C, Asimaki A, Behr ER, Sheppard MN, et al
    Myocardial Inflammation in Brugada Syndrome.
    J Am Coll Cardiol. 2019;73:1369-1370.
    PubMed    


  126. MOSARLA RC, Vaduganathan M, Qamar A, Moslehi J, et al
    Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:1336-1349.
    PubMed     Abstract available


  127. JUNEJO RT, Braz ID, Lucas SJE, van Lieshout JJ, et al
    Impaired Cerebrovascular Reactivity in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:1230-1232.
    PubMed    


  128. GIUGLIANO RP, O'Gara PT
    DOACs in Patients With Mitral Stenosis and Atrial Fibrillation: Time for a Randomized Clinical Trial.
    J Am Coll Cardiol. 2019;73:1132-1134.
    PubMed    


  129. KIM JY, Kim SH, Myong JP, Kim YR, et al
    Outcomes of Direct Oral Anticoagulants in Patients With Mitral Stenosis.
    J Am Coll Cardiol. 2019;73:1123-1131.
    PubMed     Abstract available


  130. CONEN D, Rodondi N, Muller A, Beer JH, et al
    Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:989-999.
    PubMed     Abstract available


  131. MCINTYRE WF, Healey JS, Devereaux PJ, Conen D, et al
    A Call for Randomized Trials of Oral Anticoagulation for Patients With Post-Operative Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:1105.
    PubMed    


  132. NARULA J, Ibanez B, Fuster V
    From Heart to Head, Thrombi to Emboli, and Inferences to Extrapolation.
    J Am Coll Cardiol. 2019;73:1000-1003.
    PubMed    


  133. VERHEUGT FWA
    Low Body Weight and Prescribing DOACs in Atrial Fibrillation.
    J Am Coll Cardiol. 2019;73:932-934.
    PubMed    


  134. LEE SR, Choi EK, Park CS, Han KD, et al
    Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight.
    J Am Coll Cardiol. 2019;73:919-931.
    PubMed     Abstract available


    February 2019
  135. GUGLIN M, Zucker MJ, Bazan VM, Bozkurt B, et al
    Venoarterial ECMO for Adults: JACC Scientific Expert Panel.
    J Am Coll Cardiol. 2019;73:698-716.
    PubMed     Abstract available


  136. DIENER HC, Hart RG, Koudstaal PJ, Lane DA, et al
    Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;73:612-619.
    PubMed     Abstract available


  137. ANDERSON KP
    Cardiac Amyloidosis and the Risks of Cardioversion.
    J Am Coll Cardiol. 2019;73:598-601.
    PubMed    


  138. EL-AM EA, Dispenzieri A, Melduni RM, Ammash NM, et al
    Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis.
    J Am Coll Cardiol. 2019;73:589-597.
    PubMed     Abstract available


    January 2019
  139. BORGER MA, Mansour MC, Levine RA
    Atrial Fibrillation and Mitral Valve Prolapse: Time to Intervene?
    J Am Coll Cardiol. 2019;73:275-277.
    PubMed    


  140. GRIGIONI F, Benfari G, Vanoverschelde JL, Tribouilloy C, et al
    Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation.
    J Am Coll Cardiol. 2019;73:264-274.
    PubMed     Abstract available


  141. TURAGAM MK, Lakkireddy D
    Reply: Relevant Anatomic Determinants for Epicardial Left Atrial Appendage Exclusion.
    J Am Coll Cardiol. 2019;73:381.
    PubMed    


  142. PORTA-SANCHEZ A, Pizarro G, Salvador-Montanes O, Sanchez-Quintana D, et al
    Relevant Anatomic Determinants for Epicardial Left Atrial Appendage Exclusion.
    J Am Coll Cardiol. 2019;73:380-381.
    PubMed    


  143. JANUARY CT, Wann LS, Calkins H, Chen LY, et al
    2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Hea
    J Am Coll Cardiol. 2019 Jan 21. pii: S0735-1097(19)30209.
    PubMed    


  144. BONNY A, Ngantcha M, Scholtz W, Chin A, et al
    Cardiac Arrhythmias in Africa: Epidemiology, Management Challenges, and Perspectives.
    J Am Coll Cardiol. 2019;73:100-109.
    PubMed     Abstract available


  145. OVERTCHOUK P, Guedeney P, Rouanet S, Verhoye JP, et al
    Long-Term Mortality and Early Valve Dysfunction According to Anticoagulation Use: The FRANCE TAVI Registry.
    J Am Coll Cardiol. 2019;73:13-21.
    PubMed     Abstract available


    December 2018
  146. AUFFRET V, Martins RP, Daubert C, Leclercq C, et al
    Idiopathic/Iatrogenic Left Bundle Branch Block-Induced Reversible Left Ventricle Dysfunction: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2018;72:3177-3188.
    PubMed     Abstract available


  147. ARNOLD AD, Shun-Shin MJ, Keene D, Howard JP, et al
    His Resynchronization Versus Biventricular Pacing in Patients With Heart Failure and Left Bundle Branch Block.
    J Am Coll Cardiol. 2018;72:3112-3122.
    PubMed     Abstract available


  148. MILLER MA, Dukkipati SR, Turagam M, Liao SL, et al
    Arrhythmic Mitral Valve Prolapse: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2018;72.
    PubMed     Abstract available


  149. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Left Atrial Appendage Closure in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:2806-2807.
    PubMed    


    November 2018
  150. LIN YC, Chien LN, Huang CY
    Reply: Optimal Dose of Rivaroxaban in Asians With Atrial Fibrillation: Further Studies Are Warranted.
    J Am Coll Cardiol. 2018;72:2682-2683.
    PubMed    


  151. HUANG Y, Mai L, Zhang Y, Cai X, et al
    Optimal Dose of Rivaroxaban in Asians With Atrial Fibrillation: Further Studies Are Warranted.
    J Am Coll Cardiol. 2018;72:2681-2682.
    PubMed    


  152. KIRCHHOF P, Bach M, Camm AJ
    Reply: Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World Studies.
    J Am Coll Cardiol. 2018;72:2546-2547.
    PubMed    


  153. LI HF, Hong Y
    Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World Studies.
    J Am Coll Cardiol. 2018;72:2545-2546.
    PubMed    


  154. JUNG H, Sung JH, Yang PS, Jang E, et al
    Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2018;72:2409-2411.
    PubMed    


  155. LINZ D, Brooks AG, Elliott AD, Kalman JM, et al
    Nightly Variation in Sleep Apnea Severity as Atrial Fibrillation Risk.
    J Am Coll Cardiol. 2018;72:2406-2407.
    PubMed    


    October 2018
  156. KUSUMOTO FM, Schoenfeld MH, Barrett C, Edgerton JR, et al
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guideli
    J Am Coll Cardiol. 2018 Oct 31. pii: S0735-1097(18)38984.
    PubMed    


  157. KUSUMOTO FM, Schoenfeld MH, Barrett C, Edgerton JR, et al
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart R
    J Am Coll Cardiol. 2018 Oct 31. pii: S0735-1097(18)38985.
    PubMed    


  158. SLOTWINER DJ, Raitt MH, Del-Carpio Munoz F, Mulpuru SK, et al
    Impact of Physiologic Pacing Versus Right Ventricular Pacing Among Patients With Left Ventricular Ejection Fraction Greater Than 35%: A Systematic Review for the 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia
    J Am Coll Cardiol. 2018 Oct 31. pii: S0735-1097(18)38988.
    PubMed     Abstract available


  159. CURTIS AB, Khan HA
    Should All Atrial Fibrillation Be Considered a Life-Long Problem Requiring Prophylaxis Against Thromboembolism?
    J Am Coll Cardiol. 2018;72:2037-2039.
    PubMed    


  160. BUTT JH, Olesen JB, Havers-Borgersen E, Gundlund A, et al
    Risk of Thromboembolism Associated With Atrial Fibrillation Following Noncardiac Surgery.
    J Am Coll Cardiol. 2018;72:2027-2036.
    PubMed     Abstract available


  161. JI-YOUNG LEE C, Torp-Pedersen C
    Reply: DOACs Versus Warfarin in Preventing Myocardial Infarction: Are the Benefits Worth the Price?
    J Am Coll Cardiol. 2018;72:2093-2094.
    PubMed    


  162. YE ZL, Guo WQ, Li L
    Non-VKA Oral Anticoagulant and Risk of Myocardial Infarction: Paradoxical Procoagulant Effect of Warfarin?
    J Am Coll Cardiol. 2018;72:2093.
    PubMed    


  163. ALOIA E
    DOACs Versus Warfarin in Preventing Myocardial Infarction: Are the Benefits Worth the Price?
    J Am Coll Cardiol. 2018;72:2092-2093.
    PubMed    


  164. CHEN ST, Melloni C
    Atrial Fibrillation in Cancer Patients: Recognizing Gaps in Care.
    J Am Coll Cardiol. 2018;72:1923-1925.
    PubMed    


  165. O'NEAL WT, Claxton JS, Sandesara PB, MacLehose RF, et al
    Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer.
    J Am Coll Cardiol. 2018;72:1913-1922.
    PubMed     Abstract available


  166. KOTECHA D, Pollack CV Jr, De Caterina R, Renda G, et al
    Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin.
    J Am Coll Cardiol. 2018;72:1984-1986.
    PubMed    


  167. SINDET-PEDERSEN C, Lamberts M, Staerk L, Nissen Bonde A, et al
    Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease.
    J Am Coll Cardiol. 2018;72:1790-1800.
    PubMed     Abstract available


    September 2018
  168. CORBALAN R, Nicolau JC, Lopez-Sendon J, Garcia-Castillo A, et al
    Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial.
    J Am Coll Cardiol. 2018;72:1466-1475.
    PubMed     Abstract available


  169. BUMGARNER JM, Lambert CT, Tarakji KG
    Reply: The Smartwatch Will See You Now: Implications of Mass Screening for Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:1434-1435.
    PubMed    


  170. GIANCATERINO SK, Hsu JC
    The Smartwatch Will See You Now: Implications of Mass Screening for Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:1433-1434.
    PubMed    


  171. BONDE AN, Staerk L, Lee CJ, Vinding NE, et al
    Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control.
    J Am Coll Cardiol. 2018;72:1357-1365.
    PubMed     Abstract available


  172. TURAGAM MK, Vuddanda V, Verberkmoes N, Ohtsuka T, et al
    Epicardial Left Atrial Appendage Exclusion Reduces Blood Pressure in Patients With Atrial Fibrillation and Hypertension.
    J Am Coll Cardiol. 2018;72:1346-1353.
    PubMed     Abstract available


  173. KIM D, Yang PS, Kim TH, Jang E, et al
    Ideal Blood Pressure in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:1233-1245.
    PubMed     Abstract available


  174. PHILLIPS RA, Arnold RM, Peterson LE
    Hypertension Guidelines: The Threads That Bind Them.
    J Am Coll Cardiol. 2018;72:1246-1251.
    PubMed    


    August 2018
  175. STEENSIG K, Olesen KKW, Thim T, Nielsen JC, et al
    Coronary artery disease is independent risk factor for stroke among patients with atrial fibrillation.
    J Am Coll Cardiol. 2018 Aug 23. pii: S0735-1097(18)36961.
    PubMed    


  176. LEE SR, Choi EK, Han KD, Jung JH, et al
    Edoxaban in Asian Patients With Atrial Fibrillation: Effectiveness and Safety.
    J Am Coll Cardiol. 2018;72:838-853.
    PubMed     Abstract available


  177. GANDJBAKHCH E, Redheuil A, Pousset F, Charron P, et al
    Clinical Diagnosis, Imaging, and Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2018;72:784-804.
    PubMed     Abstract available


  178. COOKE JP, Sukhovershin RA
    Novel Markers for Adverse Events in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:734-737.
    PubMed    


  179. HOROWITZ JD, De Caterina R, Heresztyn T, Alexander JH, et al
    Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy.
    J Am Coll Cardiol. 2018;72:721-733.
    PubMed     Abstract available


  180. GUHA A, Derbala MH, Zhao Q, Wiczer TE, et al
    Ventricular Arrhythmias Following Ibrutinib Initiation for Lymphoid Malignancies.
    J Am Coll Cardiol. 2018;72:697-698.
    PubMed    


  181. ALBERT CM
    Ranolazine in Patients With Implantable Cardioverter-Defibrillators: Ready for Prime Time?
    J Am Coll Cardiol. 2018;72:646-649.
    PubMed    


    July 2018
  182. LIN YC, Chien SC, Hsieh YC, Shih CM, et al
    Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:477-485.
    PubMed     Abstract available


  183. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Reply: Device-Related Thrombus After Percutaneous Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:474-475.
    PubMed    


  184. KEA B, Lin AL, Olshansky B, Malveau S, et al
    Stroke Prophylaxis After a New Emergency Department Diagnosis of Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:471-472.
    PubMed    


  185. RENDA G, De Caterina R
    Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:283-286.
    PubMed    


  186. LAW SWY, Lau WCY, Wong ICK, Lip GYH, et al
    Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:271-282.
    PubMed     Abstract available


  187. KENT AP, Brueckmann M, Fraessdorf M, Connolly SJ, et al
    Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:255-267.
    PubMed     Abstract available


  188. HEALEY JS
    Stroke Prevention in Atrial Fibrillation: What Is Real World, and What Do Real-World Data Reveal?
    J Am Coll Cardiol. 2018;72:154-155.
    PubMed    


  189. KIRCHHOF P, Radaideh G, Kim YH, Lanas F, et al
    Global Prospective Safety Analysis of Rivaroxaban.
    J Am Coll Cardiol. 2018;72:141-153.
    PubMed     Abstract available


  190. LEE CJ, Gerds TA, Carlson N, Bonde AN, et al
    Risk of Myocardial Infarction in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:17-26.
    PubMed     Abstract available


  191. LOPES RD, Rordorf R, De Ferrari GM, Leonardi S, et al
    Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed.
    J Am Coll Cardiol. 2018;72:125-126.
    PubMed    


  192. HOHNLOSER SH, Eikelboom JW
    Direct Oral Anticoagulants and Myocardial Infarction: The Dust Is Settling.
    J Am Coll Cardiol. 2018;72:27-28.
    PubMed    


    June 2018
  193. TURAGAM MK, Velagapudi P, Kar S, Holmes D, et al
    Cardiovascular Therapies Targeting Left Atrial Appendage.
    J Am Coll Cardiol. 2018 Jun 25. pii: S0735-1097(18)35139.
    PubMed     Abstract available


  194. ALKHOULI M, Noseworthy PA, Rihal CS, Holmes DR Jr, et al
    Stroke Prevention in Nonvalvular Atrial Fibrillation: A Stakeholder Perspective.
    J Am Coll Cardiol. 2018;71:2790-2801.
    PubMed     Abstract available


  195. MCCONNELL MV, Turakhia MP, Harrington RA, King AC, et al
    Mobile Health Advances in Physical Activity, Fitness, and Atrial Fibrillation: Moving Hearts.
    J Am Coll Cardiol. 2018;71:2691-2701.
    PubMed     Abstract available


  196. GLOTZER TV
    The Cacophony of Silent Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:2612-2615.
    PubMed    


  197. WONG JA, Conen D, Van Gelder IC, McIntyre WF, et al
    Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.
    J Am Coll Cardiol. 2018;71:2603-2611.
    PubMed     Abstract available


    May 2018
  198. MELA T
    Smartwatches in the Fight Against Atrial Fibrillation: The Little Watch That Could.
    J Am Coll Cardiol. 2018;71:2389-2391.
    PubMed    


  199. SZE E, Daubert JP
    Reply: Early Cardiac Resynchronization Therapy for Left Bundle Branch Block-Associated Cardiomyopathies.
    J Am Coll Cardiol. 2018;71:1945-1946.
    PubMed    


  200. WANG NC, Adelstein EC, Singh M, Voigt AH, et al
    Left Bundle Branch Block-Associated Cardiomyopathies and Early Cardiac Resynchronization Therapy: Conceptualizing a Tailored Approach.
    J Am Coll Cardiol. 2018;71:1943-1944.
    PubMed    


  201. CHATZIDOU S, Kontogiannis C, Tsilimigras DI, Georgiopoulos G, et al
    Propranolol Versus Metoprolol for Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillator.
    J Am Coll Cardiol. 2018;71:1897-1906.
    PubMed     Abstract available


    April 2018
  202. GRACE AA, Matthews GDK
    Phenotypic Landscape and Risk Management in Long QT Syndrome: Nudging Forward.
    J Am Coll Cardiol. 2018;71:1672-1675.
    PubMed    


  203. MAZZANTI A, Maragna R, Vacanti G, Monteforte N, et al
    Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome.
    J Am Coll Cardiol. 2018;71:1663-1671.
    PubMed     Abstract available


  204. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:1528-1536.
    PubMed     Abstract available


  205. YU L, Zhou L, Meng G, Jiang H, et al
    Reply: Optogenetic Neuromodulation of Stellate Ganglia for Patients With Ventricular Arrhythmias, Atrial Fibrillation, Angina, and Takotsubo?
    J Am Coll Cardiol. 2018;71:1496-1497.
    PubMed    


  206. MADIAS JE
    Optogenetic Neuromodulation of Stellate Ganglia for Patients With Ventricular Arrhythmias, Atrial Fibrillation, Angina, and Takotsubo?
    J Am Coll Cardiol. 2018;71:1495-1496.
    PubMed    


    March 2018
  207. TAYAL B, Gorcsan J 3rd, Bax JJ, Risum N, et al
    Cardiac Resynchronization Therapy in Patients With Heart Failure and Narrow QRS Complexes.
    J Am Coll Cardiol. 2018;71:1325-1333.
    PubMed     Abstract available


  208. PRABHU S, Kistler PM
    Reply: Beyond Pulmonary Vein Isolation During Catheter Ablation in Atrial Fibrillation and Systolic Dysfunction.
    J Am Coll Cardiol. 2018;71:1293-1294.
    PubMed    


  209. ALDAAS OM, Padwal J, Hsu JC
    Beyond Pulmonary Vein Isolation During Catheter Ablation in Atrial Fibrillation and Systolic Dysfunction.
    J Am Coll Cardiol. 2018;71:1292-1293.
    PubMed    


  210. TURAKHIA MP
    Digoxin in Atrial Fibrillation?: Leave it Out of the Medicine Cabinet.
    J Am Coll Cardiol. 2018;71:1075-1077.
    PubMed    


  211. LOPES RD, Rordorf R, De Ferrari GM, Leonardi S, et al
    Digoxin and Mortality in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:1063-1074.
    PubMed     Abstract available


  212. MOGENSEN UM, Kober L, McMurray JJV
    Reply: Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device.
    J Am Coll Cardiol. 2018;71:1188-1189.
    PubMed    


  213. CANEPA M, Bertero E, Brunelli C, Ameri P, et al
    Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device.
    J Am Coll Cardiol. 2018;71:1187-1188.
    PubMed    


  214. BUMGARNER JM, Lambert CT, Hussein AA, Cantillon DJ, et al
    Automated Atrial Fibrillation Detection Algorithm Using Smartwatch Technology.
    J Am Coll Cardiol. 2018 Mar 7. pii: S0735-1097(18)33486.
    PubMed     Abstract available


  215. KING JB, Marrouche N
    Reply: What Is the Biological Relationship Between Left Atrial Fibrosis and Stroke in Atrial Fibrillation?
    J Am Coll Cardiol. 2018;71:1054-1056.
    PubMed    


  216. REN JF, Callans DJ, Marchlinski FE
    What Is the Biological Relationship Between Left Atrial Fibrosis and Stroke in Atrial Fibrillation?
    J Am Coll Cardiol. 2018;71:1053-1054.
    PubMed    


    February 2018
  217. VERMA A, Bhatt DL, Verma S
    Long-Term Outcomes of Post-Operative Atrial Fibrillation: Guilty as Charged.
    J Am Coll Cardiol. 2018;71:749-751.
    PubMed    


  218. KOSMIDOU I, Chen S, Kappetein AP, Serruys PW, et al
    New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.
    J Am Coll Cardiol. 2018;71:739-748.
    PubMed     Abstract available


  219. FERREIRA JP, Girerd N, Gregson J, Latar I, et al
    Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:727-735.
    PubMed     Abstract available


  220. PASTORI D, Nocella C, Farcomeni A, Bartimoccia S, et al
    Reply: LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient?
    J Am Coll Cardiol. 2018;71:706-707.
    PubMed    


  221. EGOM EE
    LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient.
    J Am Coll Cardiol. 2018;71:705-706.
    PubMed    


    January 2018
  222. LINDE C, Braunschweig F
    Cardiomyopathy and Left Bundle Branch Block: A Farewell to Drugs?
    J Am Coll Cardiol. 2018;71:318-320.
    PubMed    


  223. SZE E, Samad Z, Dunning A, Campbell KB, et al
    Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block.
    J Am Coll Cardiol. 2018;71:306-317.
    PubMed     Abstract available


  224. SHIN JI, Luo S, Alexander GC, Inker LA, et al
    Direct Oral Anticoagulants and Risk of Acute Kidney Injury in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:251-252.
    PubMed    


  225. GONZALEZ CORCIA MC, Sieira J, Pappaert G, de Asmundis C, et al
    Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome.
    J Am Coll Cardiol. 2018;71:148-157.
    PubMed     Abstract available


  226. GAGE BF
    Stroke Prediction Rules in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:133-134.
    PubMed    


  227. CHAO TF, Lip GYH, Liu CJ, Lin YJ, et al
    Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:122-132.
    PubMed     Abstract available


    December 2017
  228. KABIR RA, Doytchinova A, Liu X, Adams D, et al
    Crescendo Skin Sympathetic Nerve Activity and Ventricular Arrhythmia.
    J Am Coll Cardiol. 2017;70:3201-3202.
    PubMed    


  229. BRUGADA P
    Short QT Syndrome and Hydroquinidine: Rare Diseases and Unavailable Drugs.
    J Am Coll Cardiol. 2017;70:3016-3017.
    PubMed    


  230. MAZZANTI A, Maragna R, Vacanti G, Kostopoulou A, et al
    Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome.
    J Am Coll Cardiol. 2017;70:3010-3015.
    PubMed     Abstract available


  231. REDDY VY, Doshi SK, Kar S, Gibson DN, et al
    5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    J Am Coll Cardiol. 2017;70:2964-2975.
    PubMed     Abstract available


  232. KHAIRY P
    Reply: Atrial Fibrillation: The Next Epidemic for Patients With Congenital Heart Disease.
    J Am Coll Cardiol. 2017;70:2950-2951.
    PubMed    


  233. TEUWEN CP, de Groot NMS
    Atrial Fibrillation: The Next Epidemic for Patients With Congenital Heart Disease.
    J Am Coll Cardiol. 2017;70:2949-2950.
    PubMed    


  234. SANDERS P, Elliott AD, Linz D
    Upstream Targets to Treat Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2906-2908.
    PubMed    


  235. TAKEMOTO Y, Ramirez RJ, Kaur K, Salvador-Montanes O, et al
    Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling.
    J Am Coll Cardiol. 2017;70:2893-2905.
    PubMed     Abstract available


  236. DUKKIPATI SR, Koruth JS, Choudry S, Miller MA, et al
    Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease: Indications, Strategies, and Outcomes-Part II.
    J Am Coll Cardiol. 2017;70:2924-2941.
    PubMed     Abstract available


  237. DUKKIPATI SR, Choudry S, Koruth JS, Miller MA, et al
    Catheter Ablation of Ventricular Tachycardia in Structurally Normal Hearts: Indications, Strategies, and Outcomes-Part I.
    J Am Coll Cardiol. 2017;70:2909-2923.
    PubMed     Abstract available


  238. YU L, Zhou L, Cao G, Po SS, et al
    Optogenetic Modulation of Cardiac Sympathetic Nerve Activity to Prevent Ventricular Arrhythmias.
    J Am Coll Cardiol. 2017;70:2778-2790.
    PubMed     Abstract available


    November 2017
  239. YAO X, Shah ND, Sangaralingham LR, Gersh BJ, et al
    Reply: NOAC Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
    J Am Coll Cardiol. 2017;70:2734-2735.
    PubMed    


  240. SHROFF GR
    NOAC Dosing in Atrial Fibrillation and Renal Dysfunction: What Measure Are You Using?
    J Am Coll Cardiol. 2017;70:2733-2734.
    PubMed    


  241. HUSSAIN A, Jain SK, Wang NC
    Improved Outcomes With Cardiology Care in Newly Diagnosed Atrial Fibrillation: Is Tachycardia-Induced Cardiomyopathy Underestimated?
    J Am Coll Cardiol. 2017;70:2730.
    PubMed    


  242. PERINO AC, Turakhia MP
    Reply: Improved Outcomes With Cardiology Care in Newly Diagnosed Atrial Fibrillation: Is Tachycardia-Induced Cardiomyopathy Underestimated?
    J Am Coll Cardiol. 2017;70:2730-2731.
    PubMed    


  243. WALSH M, Connolly SJ
    Another Dimension of Safety in the Prescription of Anticoagulants for Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2633-2635.
    PubMed    


  244. YAO X, Tangri N, Gersh BJ, Sangaralingham LR, et al
    Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2621-2632.
    PubMed     Abstract available


  245. MOGENSEN UM, Jhund PS, Abraham WT, Desai AS, et al
    Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017;70:2490-2500.
    PubMed     Abstract available


    October 2017
  246. ABU-OMAR Y, Thorpe BS, Freeman C, Mills C, et al
    Recovery of Left Atrial Contractile Function After Maze Surgery in Persistent Longstanding Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2309-2311.
    PubMed    


  247. AL-KHATIB SM, Stevenson WG, Ackerman MJ, Bryant WJ, et al
    2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the
    J Am Coll Cardiol. 2017 Oct 25. pii: S0735-1097(17)41306.
    PubMed    


  248. MILAN D
    The Com-PLEC-sity of Atrial Fibrillation Genetics.
    J Am Coll Cardiol. 2017;70:2169-2170.
    PubMed    


  249. THOROLFSDOTTIR RB, Sveinbjornsson G, Sulem P, Helgadottir A, et al
    A Missense Variant in PLEC Increases Risk of Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2157-2168.
    PubMed     Abstract available


  250. KUSUMOTO FM, Bailey KR, Chaouki AS, Deshmukh AJ, et al
    Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical P
    J Am Coll Cardiol. 2017 Oct 24. pii: S0735-1097(17)41304.
    PubMed     Abstract available


  251. AL-KHATIB SM, Stevenson WG, Ackerman MJ, Bryant WJ, et al
    2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice
    J Am Coll Cardiol. 2017 Oct 24. pii: S0735-1097(17)41305.
    PubMed    


  252. LAVIE CJ, Pandey A, Lau DH, Alpert MA, et al
    Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise.
    J Am Coll Cardiol. 2017;70:2022-2035.
    PubMed     Abstract available


  253. HERNANDEZ-OJEDA J, Arbelo E, Borras R, Berne P, et al
    Patients With Brugada Syndrome and Implanted Cardioverter-Defibrillators: Long-Term Follow-Up.
    J Am Coll Cardiol. 2017;70:1991-2002.
    PubMed     Abstract available


  254. BARON-ESQUIVIAS G, Morillo CA, Moya-Mitjans A, Martinez-Alday J, et al
    Dual-Chamber Pacing With Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope: The SPAIN Study.
    J Am Coll Cardiol. 2017;70:1720-1728.
    PubMed     Abstract available


    September 2017
  255. PAQUETTE M, Riou Franca L, Teutsch C, Diener HC, et al
    Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1573-1583.
    PubMed     Abstract available


  256. NICHOL G, Sayre MR, Guerra F, Poole J, et al
    Defibrillation for Ventricular Fibrillation: A Shocking Update.
    J Am Coll Cardiol. 2017;70:1496-1509.
    PubMed     Abstract available


  257. PASTORI D, Nocella C, Farcomeni A, Bartimoccia S, et al
    Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1455-1462.
    PubMed     Abstract available


  258. BOCCHI EA, Bestetti RB, Scanavacca MI, Cunha Neto E, et al
    Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment.
    J Am Coll Cardiol. 2017;70:1510-1524.
    PubMed     Abstract available


  259. DEBATY G, Labarere J, Frascone RJ, Wayne MA, et al
    Long-Term Prognostic Value of Gasping During Out-of-Hospital Cardiac Arrest.
    J Am Coll Cardiol. 2017;70:1467-1476.
    PubMed     Abstract available


  260. GURBEL PA, Navarese EP, Tantry US
    Exploration of PCSK9 as a Cardiovascular Risk Factor: Is There a Link to the Platelet?
    J Am Coll Cardiol. 2017;70:1463-1466.
    PubMed    


  261. BLOOMGARDEN ZT, Kosiborod MN, Handelsman Y
    Concomitant Diabetes and Atrial Fibrillation: No Sugarcoating the Bittersweet Reality.
    J Am Coll Cardiol. 2017;70:1336-1338.
    PubMed    


  262. ECHOUFFO-TCHEUGUI JB, Shrader P, Thomas L, Gersh BJ, et al
    Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.
    J Am Coll Cardiol. 2017;70:1325-1335.
    PubMed     Abstract available


  263. NAZARIAN S, Zghaib T
    Is Atrial Fibrillation a Necessary Component of the Thrombogenic Atrium?
    J Am Coll Cardiol. 2017;70:1322-1324.
    PubMed    


  264. KING JB, Azadani PN, Suksaranjit P, Bress AP, et al
    Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1311-1321.
    PubMed     Abstract available


  265. ESCANDE W, Boveda S, Defaye P, Leclercq C, et al
    Outcomes in Guideline-Based Versus Off-Guideline Primary Prevention Implantable Cardioverter-Defibrillator Recipients.
    J Am Coll Cardiol. 2017;70:1302-1303.
    PubMed    


    August 2017
  266. DESIMONE CV, Graff-Radford J, El-Harasis MA, Rabinstein AA, et al
    Cerebral Amyloid Angiopathy: Diagnosis, Clinical Implications, and Management Strategies in Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1173-1182.
    PubMed     Abstract available


  267. YANNOPOULOS D, Bartos JA, Raveendran G, Conterato M, et al
    Coronary Artery Disease in Patients With Out-of-Hospital Refractory Ventricular Fibrillation Cardiac Arrest.
    J Am Coll Cardiol. 2017;70:1109-1117.
    PubMed     Abstract available


  268. WAZNI O, Chung MK
    Catheter Ablation for Rate Controlled Atrial Fibrillation: New Horizon in Heart Failure Treatment.
    J Am Coll Cardiol. 2017 Aug 22. pii: S0735-1097(17)39348.
    PubMed    


  269. PRABHU S, Taylor AJ, Costello BT, Kaye DM, et al
    Catheter Ablation Versus Medical Rate control in Atrial Fibrillation and Systolic Dysfunction (CAMERA-MRI).
    J Am Coll Cardiol. 2017 Aug 22. pii: S0735-1097(17)39349.
    PubMed     Abstract available


  270. SILKA MJ, Bar-Cohen Y
    Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease: Sequel or Series?
    J Am Coll Cardiol. 2017;70:866-868.
    PubMed    


  271. LABOMBARDA F, Hamilton R, Shohoudi A, Aboulhosn J, et al
    Increasing Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease.
    J Am Coll Cardiol. 2017;70:857-865.
    PubMed     Abstract available


  272. POOLE JE, Prutkin JM
    Subcutaneous Implantable Cardioverter-Defibrillator Finding a Place in Sudden Cardiac Death Prevention: Emerging or Emerged?
    J Am Coll Cardiol. 2017;70:842-844.
    PubMed    


  273. BOERSMA L, Barr C, Knops R, Theuns D, et al
    Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.
    J Am Coll Cardiol. 2017;70:830-841.
    PubMed     Abstract available


  274. IWASAWA J, Koruth JS, Petru J, Dujka L, et al
    Temperature-Controlled Radiofrequency Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:542-553.
    PubMed     Abstract available


    July 2017
  275. SCHWARTZ PJ, Dagradi F, Castelletti S
    Evolution in Managing Long QT Syndrome: From Registries to Centers of Excellence.
    J Am Coll Cardiol. 2017;70:463-465.
    PubMed    


  276. ROHATGI RK, Sugrue A, Bos JM, Cannon BC, et al
    Contemporary Outcomes in Patients With Long QT Syndrome.
    J Am Coll Cardiol. 2017;70:453-462.
    PubMed     Abstract available


  277. SEKI A, Ishikawa T, Daumy X, Mishima H, et al
    Progressive Atrial Conduction Defects Associated With Bone Malformation Caused by a Connexin-45 Mutation.
    J Am Coll Cardiol. 2017;70:358-370.
    PubMed     Abstract available


  278. EPPINGA RN, Hartman MHT, Verweij N, van der Harst JJ, et al
    Refining Thromboembolic Risk in the General Population.
    J Am Coll Cardiol. 2017;70:403-404.
    PubMed    


  279. WHANG W
    Opportunities to Improve Outcomes in Atrial Fibrillation: Provider Specialty and Beyond.
    J Am Coll Cardiol. 2017;70:87-88.
    PubMed    


  280. PERINO AC, Fan J, Schmitt SK, Askari M, et al
    Treating Specialty and Outcomes in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
    J Am Coll Cardiol. 2017;70:78-86.
    PubMed     Abstract available


    June 2017
  281. MILLER MA, Palaniswamy C, Dukkipati SR, Balulad S, et al
    Subcutaneous Implantable Cardioverter-Defibrillator Implantation Without Defibrillation Testing.
    J Am Coll Cardiol. 2017;69:3118-3119.
    PubMed    


  282. VASEGHI M, Barwad P, Malavassi Corrales FJ, Tandri H, et al
    Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias.
    J Am Coll Cardiol. 2017;69:3070-3080.
    PubMed     Abstract available


  283. VIJAYARAMAN P, Bordachar P, Ellenbogen KA
    The Continued Search for Physiological Pacing: Where Are We Now?
    J Am Coll Cardiol. 2017;69:3099-3114.
    PubMed     Abstract available


  284. HALPERIN JL
    Preventing Myocardial Infarction in Patients With Atrial Fibrillation: Another Piece of the Puzzle.
    J Am Coll Cardiol. 2017;69:2910-2912.
    PubMed    


  285. LEE CJ, Pallisgaard JL, Olesen JB, Carlson N, et al
    Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2901-2909.
    PubMed     Abstract available


  286. FILIPPATOS G, Farmakis D
    How to Use Beta-Blockers in Heart Failure With Reduced Ejection Fraction and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2897-2900.
    PubMed    


  287. YAO X, Shah ND, Sangaralingham LR, Gersh BJ, et al
    Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
    J Am Coll Cardiol. 2017;69:2779-2790.
    PubMed     Abstract available


    May 2017
  288. SOLOMON SD, Chatterjee NA
    Who Benefits From Implantable Cardioverter-Defibrillators?: Integrating Absolute, Proportional, and Competing Risk.
    J Am Coll Cardiol. 2017;69:2619-2621.
    PubMed    


  289. BILCHICK KC, Wang Y, Cheng A, Curtis JP, et al
    Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
    J Am Coll Cardiol. 2017;69:2606-2618.
    PubMed     Abstract available


  290. O'KEEFE JH, DiNicolantonio JJ
    Alcohol and Atrial Fibrillation: Mitigating the Risk.
    J Am Coll Cardiol. 2017;69:2578.
    PubMed    


  291. NATTEL S
    Atrial Fibrillation and Body Composition: Is it Fat or Lean That Ultimately Determines the Risk?
    J Am Coll Cardiol. 2017;69:2498-2501.
    PubMed    


  292. FENGER-GRON M, Overvad K, Tjonneland A, Frost L, et al
    Lean Body Mass Is the Predominant Anthropometric Risk Factor for Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2488-2497.
    PubMed     Abstract available


  293. PETERSON ED, Pokorney SD
    New Treatment Options Fail to Close the Anticoagulation Gap in Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2485-2487.
    PubMed    


  294. MARZEC LN, Wang J, Shah ND, Chan PS, et al
    Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2475-2484.
    PubMed     Abstract available


  295. DORKS M, Jobski K, Herget-Rosenthal S, Hoffmann F, et al
    Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.
    J Am Coll Cardiol. 2017;69:2471.
    PubMed    


  296. CHAN YH, Kuo CT
    Reply: Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.
    J Am Coll Cardiol. 2017;69:2471-2472.
    PubMed    


  297. MUELLER KAL, Heinzmann D, Klingel K, Fallier-Becker P, et al
    Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy.
    J Am Coll Cardiol. 2017;69:2160-2172.
    PubMed     Abstract available


  298. SANTANGELI P, Frankel DS, Tung R, Vaseghi M, et al
    Early Mortality After Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease.
    J Am Coll Cardiol. 2017;69:2105-2115.
    PubMed     Abstract available


    April 2017
  299. HUCKER WJ, Hanley A, Ellinor PT
    Improving Atrial Fibrillation Therapy: Is There a Gene for That?
    J Am Coll Cardiol. 2017;69:2088-2095.
    PubMed     Abstract available


  300. SUNDARAM V, Sahadevan J, Waldo AL, Stukenborg GJ, et al
    Implantable Cardioverter-Defibrillators With Versus Without Resynchronization Therapy in Patients With a QRS Duration >180 ms.
    J Am Coll Cardiol. 2017;69:2026-2036.
    PubMed     Abstract available


  301. HOBBELT AH, Spronk HM, Crijns HJ, Ten Cate H, et al
    Prethrombotic State in Young Very Low-Risk Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1990-1992.
    PubMed    


  302. DU X, Dong J, Ma C
    Is Atrial Fibrillation a Preventable Disease?
    J Am Coll Cardiol. 2017;69:1968-1982.
    PubMed     Abstract available


  303. LORBERBAUM T, Tatonetti NP
    Reply: Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome and Torsades de Pointes Risk.
    J Am Coll Cardiol. 2017;69:1877-1878.
    PubMed    


  304. LAZZERINI PE, Bertolozzi I, Rossi M, Capecchi PL, et al
    Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk.
    J Am Coll Cardiol. 2017;69:1876-1877.
    PubMed    


  305. SANTANGELI P, Rame JE, Birati EY, Marchlinski FE, et al
    Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure.
    J Am Coll Cardiol. 2017;69:1842-1860.
    PubMed     Abstract available


  306. DRIESSEN AH, Berger WR, Chan Pin Yin DR, Piersma FR, et al
    Electrophysiologically Guided Thoracoscopic Surgery for Advanced Atrial Fibrillation: 5-Year Follow-up.
    J Am Coll Cardiol. 2017;69:1753-1754.
    PubMed    


  307. FLETCHER G
    Atrial Fibrillation: A Threat to the Failing Heart?
    J Am Coll Cardiol. 2017;69:1692-1693.
    PubMed    


  308. LUO N, Merrill P, Parikh KS, Whellan DJ, et al
    Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1683-1691.
    PubMed     Abstract available


    March 2017
  309. DE CATERINA R, Renda G, Carnicelli AP, Nordio F, et al
    Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
    J Am Coll Cardiol. 2017;69:1372-1382.
    PubMed     Abstract available


  310. ARBUSTINI E, Favalli V, Narula N, Serio A, et al
    Reply: A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic Dilation.
    J Am Coll Cardiol. 2017;69:1210-1211.
    PubMed    


  311. SCHWEIZER PA, Koenen M, Katus HA, Thomas D, et al
    A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic Dilation.
    J Am Coll Cardiol. 2017;69:1209-1210.
    PubMed    


    February 2017
  312. SHARMA S, Drezner JA, Baggish A, Papadakis M, et al
    International Recommendations for Electrocardiographic Interpretation in Athletes.
    J Am Coll Cardiol. 2017;69:1057-1075.
    PubMed     Abstract available


  313. HUISMAN MV, Rothman KJ, Paquette M, Teutsch C, et al
    The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.
    J Am Coll Cardiol. 2017;69:777-785.
    PubMed     Abstract available


  314. VADUGANATHAN M, Patel RB, Michel A, Shah SJ, et al
    Mode of Death in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;69:556-569.
    PubMed     Abstract available


  315. VENLET J, Piers SR, Jongbloed JD, Androulakis AF, et al
    Isolated Subepicardial Right Ventricular Outflow Tract Scar in Athletes With Ventricular Tachycardia.
    J Am Coll Cardiol. 2017;69:497-507.
    PubMed     Abstract available


    January 2017
  316. VAL-BLASCO A, Piedras MJ, Ruiz-Hurtado G, Suarez N, et al
    Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling.
    J Am Coll Cardiol. 2017;69:423-433.
    PubMed     Abstract available


  317. SEITZ J, Bars C, Theodore G, Beurtheret S, et al
    AF Ablation Guided by Spatiotemporal Electrogram Dispersion Without Pulmonary Vein Isolation: A Wholly Patient-Tailored Approach.
    J Am Coll Cardiol. 2017;69:303-321.
    PubMed     Abstract available


  318. MADHAVAN M, Mulpuru SK, McLeod CJ, Cha YM, et al
    Advances and Future Directions in Cardiac Pacemakers: Part 2 of a 2-Part Series.
    J Am Coll Cardiol. 2017;69:211-235.
    PubMed     Abstract available


  319. MULPURU SK, Madhavan M, McLeod CJ, Cha YM, et al
    Cardiac Pacemakers: Function, Troubleshooting, and Management: Part 1 of a 2-Part Series.
    J Am Coll Cardiol. 2017;69:189-210.
    PubMed     Abstract available


    August 2016
  320. PARASHAR A, Sud K, Devgun J, Agarwal S, et al
    Feasibility of LAA Closure for Left Atrial Thrombus in Patients With Aortic Stenosis and AF.
    J Am Coll Cardiol. 2016;68:770-1.
    PubMed    


    May 2016
  321. SINNECKER D, Dommasch M, Steger A, Berkefeld A, et al
    Expiration-Triggered Sinus Arrhythmia Predicts Outcome in Survivors of Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;67:2213-20.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: